nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2B6—Simvastatin—atherosclerosis	0.133	0.217	CbGbCtD
Ropivacaine—CYP2D6—Niacin—atherosclerosis	0.0811	0.133	CbGbCtD
Ropivacaine—CYP2D6—Simvastatin—atherosclerosis	0.0641	0.105	CbGbCtD
Ropivacaine—CYP2D6—Pravastatin—atherosclerosis	0.0627	0.103	CbGbCtD
Ropivacaine—CYP2D6—Lovastatin—atherosclerosis	0.0627	0.103	CbGbCtD
Ropivacaine—CYP3A4—Ezetimibe—atherosclerosis	0.0439	0.0717	CbGbCtD
Ropivacaine—CYP3A4—Rosuvastatin—atherosclerosis	0.0439	0.0717	CbGbCtD
Ropivacaine—CYP3A4—Simvastatin—atherosclerosis	0.0408	0.0666	CbGbCtD
Ropivacaine—CYP3A4—Lovastatin—atherosclerosis	0.0399	0.0652	CbGbCtD
Ropivacaine—CYP3A4—Pravastatin—atherosclerosis	0.0399	0.0652	CbGbCtD
Ropivacaine—Angioedema—Rosuvastatin—atherosclerosis	0.00104	0.00304	CcSEcCtD
Ropivacaine—Jaundice—Niacin—atherosclerosis	0.00103	0.00302	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00103	0.00301	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00102	0.00299	CcSEcCtD
Ropivacaine—Myocardial infarction—Pravastatin—atherosclerosis	0.00102	0.00299	CcSEcCtD
Ropivacaine—Jaundice—Pravastatin—atherosclerosis	0.00102	0.00298	CcSEcCtD
Ropivacaine—Urinary tract infection—Pravastatin—atherosclerosis	0.00101	0.00297	CcSEcCtD
Ropivacaine—Chills—Lovastatin—atherosclerosis	0.000993	0.00291	CcSEcCtD
Ropivacaine—Cough—Rosuvastatin—atherosclerosis	0.000992	0.0029	CcSEcCtD
Ropivacaine—Arthralgia—Rosuvastatin—atherosclerosis	0.000968	0.00283	CcSEcCtD
Ropivacaine—Myalgia—Rosuvastatin—atherosclerosis	0.000968	0.00283	CcSEcCtD
Ropivacaine—Rhinitis—Niacin—atherosclerosis	0.000953	0.00279	CcSEcCtD
Ropivacaine—Mental disorder—Ezetimibe—atherosclerosis	0.000951	0.00278	CcSEcCtD
Ropivacaine—Hypoaesthesia—Niacin—atherosclerosis	0.000946	0.00277	CcSEcCtD
Ropivacaine—Erythema—Ezetimibe—atherosclerosis	0.000945	0.00277	CcSEcCtD
Ropivacaine—Rhinitis—Pravastatin—atherosclerosis	0.000939	0.00275	CcSEcCtD
Ropivacaine—Oedema peripheral—Niacin—atherosclerosis	0.000937	0.00274	CcSEcCtD
Ropivacaine—Confusional state—Rosuvastatin—atherosclerosis	0.000936	0.00274	CcSEcCtD
Ropivacaine—Back pain—Lovastatin—atherosclerosis	0.000932	0.00273	CcSEcCtD
Ropivacaine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000932	0.00273	CcSEcCtD
Ropivacaine—Chills—Simvastatin—atherosclerosis	0.000929	0.00272	CcSEcCtD
Ropivacaine—Muscle spasms—Lovastatin—atherosclerosis	0.000927	0.00271	CcSEcCtD
Ropivacaine—Infection—Rosuvastatin—atherosclerosis	0.000922	0.0027	CcSEcCtD
Ropivacaine—Back pain—Ezetimibe—atherosclerosis	0.000914	0.00268	CcSEcCtD
Ropivacaine—Muscle spasms—Ezetimibe—atherosclerosis	0.000909	0.00266	CcSEcCtD
Ropivacaine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000909	0.00266	CcSEcCtD
Ropivacaine—Vision blurred—Lovastatin—atherosclerosis	0.000908	0.00266	CcSEcCtD
Ropivacaine—Mental disorder—Simvastatin—atherosclerosis	0.000907	0.00266	CcSEcCtD
Ropivacaine—Tremor—Lovastatin—atherosclerosis	0.000903	0.00264	CcSEcCtD
Ropivacaine—Erythema—Simvastatin—atherosclerosis	0.000902	0.00264	CcSEcCtD
Ropivacaine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000894	0.00262	CcSEcCtD
Ropivacaine—Tinnitus—Niacin—atherosclerosis	0.000887	0.0026	CcSEcCtD
Ropivacaine—Angioedema—Lovastatin—atherosclerosis	0.000881	0.00258	CcSEcCtD
Ropivacaine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000877	0.00257	CcSEcCtD
Ropivacaine—Anaemia—Ezetimibe—atherosclerosis	0.000874	0.00256	CcSEcCtD
Ropivacaine—Tinnitus—Pravastatin—atherosclerosis	0.000873	0.00256	CcSEcCtD
Ropivacaine—Malaise—Lovastatin—atherosclerosis	0.000869	0.00254	CcSEcCtD
Ropivacaine—Cardiac disorder—Pravastatin—atherosclerosis	0.000869	0.00254	CcSEcCtD
Ropivacaine—Muscle spasms—Simvastatin—atherosclerosis	0.000867	0.00254	CcSEcCtD
Ropivacaine—Vertigo—Lovastatin—atherosclerosis	0.000866	0.00253	CcSEcCtD
Ropivacaine—Angioedema—Ezetimibe—atherosclerosis	0.000864	0.00253	CcSEcCtD
Ropivacaine—Chills—Niacin—atherosclerosis	0.000853	0.0025	CcSEcCtD
Ropivacaine—Malaise—Ezetimibe—atherosclerosis	0.000852	0.0025	CcSEcCtD
Ropivacaine—Vision blurred—Simvastatin—atherosclerosis	0.00085	0.00249	CcSEcCtD
Ropivacaine—Arrhythmia—Niacin—atherosclerosis	0.000849	0.00249	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000846	0.00248	CcSEcCtD
Ropivacaine—Tremor—Simvastatin—atherosclerosis	0.000845	0.00247	CcSEcCtD
Ropivacaine—Chills—Pravastatin—atherosclerosis	0.00084	0.00246	CcSEcCtD
Ropivacaine—Insomnia—Rosuvastatin—atherosclerosis	0.000839	0.00246	CcSEcCtD
Ropivacaine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000836	0.00245	CcSEcCtD
Ropivacaine—Arrhythmia—Pravastatin—atherosclerosis	0.000836	0.00245	CcSEcCtD
Ropivacaine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000833	0.00244	CcSEcCtD
Ropivacaine—Anaemia—Simvastatin—atherosclerosis	0.000833	0.00244	CcSEcCtD
Ropivacaine—Erythema—Niacin—atherosclerosis	0.000828	0.00242	CcSEcCtD
Ropivacaine—Cough—Ezetimibe—atherosclerosis	0.000825	0.00241	CcSEcCtD
Ropivacaine—Angioedema—Simvastatin—atherosclerosis	0.000824	0.00241	CcSEcCtD
Ropivacaine—Chest pain—Lovastatin—atherosclerosis	0.000821	0.0024	CcSEcCtD
Ropivacaine—Arthralgia—Lovastatin—atherosclerosis	0.000821	0.0024	CcSEcCtD
Ropivacaine—Myalgia—Lovastatin—atherosclerosis	0.000821	0.0024	CcSEcCtD
Ropivacaine—Anxiety—Lovastatin—atherosclerosis	0.000818	0.00239	CcSEcCtD
Ropivacaine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000817	0.00239	CcSEcCtD
Ropivacaine—Hypertension—Ezetimibe—atherosclerosis	0.000816	0.00239	CcSEcCtD
Ropivacaine—Malaise—Simvastatin—atherosclerosis	0.000813	0.00238	CcSEcCtD
Ropivacaine—Tension—Niacin—atherosclerosis	0.000812	0.00238	CcSEcCtD
Ropivacaine—Discomfort—Lovastatin—atherosclerosis	0.000811	0.00237	CcSEcCtD
Ropivacaine—Vertigo—Simvastatin—atherosclerosis	0.00081	0.00237	CcSEcCtD
Ropivacaine—Myalgia—Ezetimibe—atherosclerosis	0.000805	0.00236	CcSEcCtD
Ropivacaine—Arthralgia—Ezetimibe—atherosclerosis	0.000805	0.00236	CcSEcCtD
Ropivacaine—Chest pain—Ezetimibe—atherosclerosis	0.000805	0.00236	CcSEcCtD
Ropivacaine—Nervousness—Niacin—atherosclerosis	0.000804	0.00235	CcSEcCtD
Ropivacaine—Tension—Pravastatin—atherosclerosis	0.0008	0.00234	CcSEcCtD
Ropivacaine—Muscle spasms—Niacin—atherosclerosis	0.000796	0.00233	CcSEcCtD
Ropivacaine—Discomfort—Ezetimibe—atherosclerosis	0.000795	0.00233	CcSEcCtD
Ropivacaine—Pain—Rosuvastatin—atherosclerosis	0.000794	0.00232	CcSEcCtD
Ropivacaine—Constipation—Rosuvastatin—atherosclerosis	0.000794	0.00232	CcSEcCtD
Ropivacaine—Confusional state—Lovastatin—atherosclerosis	0.000793	0.00232	CcSEcCtD
Ropivacaine—Nervousness—Pravastatin—atherosclerosis	0.000792	0.00232	CcSEcCtD
Ropivacaine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000787	0.0023	CcSEcCtD
Ropivacaine—Muscle spasms—Pravastatin—atherosclerosis	0.000784	0.00229	CcSEcCtD
Ropivacaine—Infection—Lovastatin—atherosclerosis	0.000781	0.00229	CcSEcCtD
Ropivacaine—Vision blurred—Niacin—atherosclerosis	0.00078	0.00228	CcSEcCtD
Ropivacaine—Confusional state—Ezetimibe—atherosclerosis	0.000778	0.00228	CcSEcCtD
Ropivacaine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000772	0.00226	CcSEcCtD
Ropivacaine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00077	0.00225	CcSEcCtD
Ropivacaine—Vision blurred—Pravastatin—atherosclerosis	0.000768	0.00225	CcSEcCtD
Ropivacaine—Myalgia—Simvastatin—atherosclerosis	0.000768	0.00225	CcSEcCtD
Ropivacaine—Arthralgia—Simvastatin—atherosclerosis	0.000768	0.00225	CcSEcCtD
Ropivacaine—Chest pain—Simvastatin—atherosclerosis	0.000768	0.00225	CcSEcCtD
Ropivacaine—Infection—Ezetimibe—atherosclerosis	0.000766	0.00224	CcSEcCtD
Ropivacaine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000765	0.00224	CcSEcCtD
Ropivacaine—Anxiety—Simvastatin—atherosclerosis	0.000765	0.00224	CcSEcCtD
Ropivacaine—Tremor—Pravastatin—atherosclerosis	0.000764	0.00224	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000759	0.00222	CcSEcCtD
Ropivacaine—Discomfort—Simvastatin—atherosclerosis	0.000758	0.00222	CcSEcCtD
Ropivacaine—Angioedema—Niacin—atherosclerosis	0.000756	0.00221	CcSEcCtD
Ropivacaine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000756	0.00221	CcSEcCtD
Ropivacaine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000755	0.00221	CcSEcCtD
Ropivacaine—Anaemia—Pravastatin—atherosclerosis	0.000753	0.0022	CcSEcCtD
Ropivacaine—Skin disorder—Ezetimibe—atherosclerosis	0.000749	0.00219	CcSEcCtD
Ropivacaine—Angioedema—Pravastatin—atherosclerosis	0.000745	0.00218	CcSEcCtD
Ropivacaine—Vertigo—Niacin—atherosclerosis	0.000744	0.00218	CcSEcCtD
Ropivacaine—Syncope—Niacin—atherosclerosis	0.000742	0.00217	CcSEcCtD
Ropivacaine—Confusional state—Simvastatin—atherosclerosis	0.000742	0.00217	CcSEcCtD
Ropivacaine—Urticaria—Rosuvastatin—atherosclerosis	0.000737	0.00216	CcSEcCtD
Ropivacaine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000736	0.00215	CcSEcCtD
Ropivacaine—Malaise—Pravastatin—atherosclerosis	0.000735	0.00215	CcSEcCtD
Ropivacaine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000734	0.00215	CcSEcCtD
Ropivacaine—Vertigo—Pravastatin—atherosclerosis	0.000732	0.00214	CcSEcCtD
Ropivacaine—Infection—Simvastatin—atherosclerosis	0.000731	0.00214	CcSEcCtD
Ropivacaine—Loss of consciousness—Niacin—atherosclerosis	0.000728	0.00213	CcSEcCtD
Ropivacaine—Cough—Niacin—atherosclerosis	0.000722	0.00211	CcSEcCtD
Ropivacaine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00072	0.00211	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000717	0.0021	CcSEcCtD
Ropivacaine—Insomnia—Lovastatin—atherosclerosis	0.000711	0.00208	CcSEcCtD
Ropivacaine—Cough—Pravastatin—atherosclerosis	0.000711	0.00208	CcSEcCtD
Ropivacaine—Paraesthesia—Lovastatin—atherosclerosis	0.000706	0.00207	CcSEcCtD
Ropivacaine—Arthralgia—Niacin—atherosclerosis	0.000705	0.00206	CcSEcCtD
Ropivacaine—Myalgia—Niacin—atherosclerosis	0.000705	0.00206	CcSEcCtD
Ropivacaine—Hypertension—Pravastatin—atherosclerosis	0.000704	0.00206	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000703	0.00206	CcSEcCtD
Ropivacaine—Dyspnoea—Lovastatin—atherosclerosis	0.000701	0.00205	CcSEcCtD
Ropivacaine—Insomnia—Ezetimibe—atherosclerosis	0.000698	0.00204	CcSEcCtD
Ropivacaine—Myalgia—Pravastatin—atherosclerosis	0.000694	0.00203	CcSEcCtD
Ropivacaine—Chest pain—Pravastatin—atherosclerosis	0.000694	0.00203	CcSEcCtD
Ropivacaine—Arthralgia—Pravastatin—atherosclerosis	0.000694	0.00203	CcSEcCtD
Ropivacaine—Paraesthesia—Ezetimibe—atherosclerosis	0.000693	0.00203	CcSEcCtD
Ropivacaine—Dyspepsia—Lovastatin—atherosclerosis	0.000692	0.00203	CcSEcCtD
Ropivacaine—Anxiety—Pravastatin—atherosclerosis	0.000691	0.00202	CcSEcCtD
Ropivacaine—Dyspnoea—Ezetimibe—atherosclerosis	0.000688	0.00201	CcSEcCtD
Ropivacaine—Discomfort—Pravastatin—atherosclerosis	0.000686	0.00201	CcSEcCtD
Ropivacaine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000684	0.002	CcSEcCtD
Ropivacaine—Dyspepsia—Ezetimibe—atherosclerosis	0.000679	0.00199	CcSEcCtD
Ropivacaine—Anaphylactic shock—Niacin—atherosclerosis	0.000676	0.00198	CcSEcCtD
Ropivacaine—Constipation—Lovastatin—atherosclerosis	0.000673	0.00197	CcSEcCtD
Ropivacaine—Pain—Lovastatin—atherosclerosis	0.000673	0.00197	CcSEcCtD
Ropivacaine—Confusional state—Pravastatin—atherosclerosis	0.000671	0.00196	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00067	0.00196	CcSEcCtD
Ropivacaine—Asthenia—Rosuvastatin—atherosclerosis	0.000666	0.00195	CcSEcCtD
Ropivacaine—Insomnia—Simvastatin—atherosclerosis	0.000665	0.00195	CcSEcCtD
Ropivacaine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000665	0.00195	CcSEcCtD
Ropivacaine—Shock—Niacin—atherosclerosis	0.000665	0.00195	CcSEcCtD
Ropivacaine—Infection—Pravastatin—atherosclerosis	0.000661	0.00193	CcSEcCtD
Ropivacaine—Paraesthesia—Simvastatin—atherosclerosis	0.000661	0.00193	CcSEcCtD
Ropivacaine—Pain—Ezetimibe—atherosclerosis	0.00066	0.00193	CcSEcCtD
Ropivacaine—Constipation—Ezetimibe—atherosclerosis	0.00066	0.00193	CcSEcCtD
Ropivacaine—Tachycardia—Niacin—atherosclerosis	0.000659	0.00193	CcSEcCtD
Ropivacaine—Pruritus—Rosuvastatin—atherosclerosis	0.000657	0.00192	CcSEcCtD
Ropivacaine—Skin disorder—Niacin—atherosclerosis	0.000656	0.00192	CcSEcCtD
Ropivacaine—Dyspnoea—Simvastatin—atherosclerosis	0.000656	0.00192	CcSEcCtD
Ropivacaine—Hyperhidrosis—Niacin—atherosclerosis	0.000653	0.00191	CcSEcCtD
Ropivacaine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000651	0.00191	CcSEcCtD
Ropivacaine—Feeling abnormal—Lovastatin—atherosclerosis	0.000648	0.0019	CcSEcCtD
Ropivacaine—Dyspepsia—Simvastatin—atherosclerosis	0.000648	0.0019	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000643	0.00188	CcSEcCtD
Ropivacaine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000643	0.00188	CcSEcCtD
Ropivacaine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000636	0.00186	CcSEcCtD
Ropivacaine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000635	0.00186	CcSEcCtD
Ropivacaine—Hypotension—Niacin—atherosclerosis	0.000631	0.00185	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000631	0.00185	CcSEcCtD
Ropivacaine—Pain—Simvastatin—atherosclerosis	0.000629	0.00184	CcSEcCtD
Ropivacaine—Constipation—Simvastatin—atherosclerosis	0.000629	0.00184	CcSEcCtD
Ropivacaine—Urticaria—Lovastatin—atherosclerosis	0.000625	0.00183	CcSEcCtD
Ropivacaine—Body temperature increased—Lovastatin—atherosclerosis	0.000622	0.00182	CcSEcCtD
Ropivacaine—Abdominal pain—Lovastatin—atherosclerosis	0.000622	0.00182	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000616	0.0018	CcSEcCtD
Ropivacaine—Dizziness—Rosuvastatin—atherosclerosis	0.000614	0.0018	CcSEcCtD
Ropivacaine—Urticaria—Ezetimibe—atherosclerosis	0.000613	0.00179	CcSEcCtD
Ropivacaine—Insomnia—Niacin—atherosclerosis	0.000611	0.00179	CcSEcCtD
Ropivacaine—Abdominal pain—Ezetimibe—atherosclerosis	0.00061	0.00179	CcSEcCtD
Ropivacaine—Body temperature increased—Ezetimibe—atherosclerosis	0.00061	0.00179	CcSEcCtD
Ropivacaine—Paraesthesia—Niacin—atherosclerosis	0.000607	0.00178	CcSEcCtD
Ropivacaine—Feeling abnormal—Simvastatin—atherosclerosis	0.000606	0.00177	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000606	0.00177	CcSEcCtD
Ropivacaine—Dyspnoea—Niacin—atherosclerosis	0.000602	0.00176	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000602	0.00176	CcSEcCtD
Ropivacaine—Insomnia—Pravastatin—atherosclerosis	0.000602	0.00176	CcSEcCtD
Ropivacaine—Somnolence—Niacin—atherosclerosis	0.000601	0.00176	CcSEcCtD
Ropivacaine—Paraesthesia—Pravastatin—atherosclerosis	0.000597	0.00175	CcSEcCtD
Ropivacaine—Dyspepsia—Niacin—atherosclerosis	0.000595	0.00174	CcSEcCtD
Ropivacaine—Dyspnoea—Pravastatin—atherosclerosis	0.000593	0.00174	CcSEcCtD
Ropivacaine—Dyspepsia—Pravastatin—atherosclerosis	0.000586	0.00171	CcSEcCtD
Ropivacaine—Rash—Rosuvastatin—atherosclerosis	0.000585	0.00171	CcSEcCtD
Ropivacaine—Dermatitis—Rosuvastatin—atherosclerosis	0.000585	0.00171	CcSEcCtD
Ropivacaine—Urticaria—Simvastatin—atherosclerosis	0.000584	0.00171	CcSEcCtD
Ropivacaine—Abdominal pain—Simvastatin—atherosclerosis	0.000582	0.0017	CcSEcCtD
Ropivacaine—Body temperature increased—Simvastatin—atherosclerosis	0.000582	0.0017	CcSEcCtD
Ropivacaine—Headache—Rosuvastatin—atherosclerosis	0.000581	0.0017	CcSEcCtD
Ropivacaine—Hypersensitivity—Lovastatin—atherosclerosis	0.00058	0.0017	CcSEcCtD
Ropivacaine—Pain—Niacin—atherosclerosis	0.000578	0.00169	CcSEcCtD
Ropivacaine—Pain—Pravastatin—atherosclerosis	0.000569	0.00166	CcSEcCtD
Ropivacaine—Constipation—Pravastatin—atherosclerosis	0.000569	0.00166	CcSEcCtD
Ropivacaine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000568	0.00166	CcSEcCtD
Ropivacaine—Asthenia—Lovastatin—atherosclerosis	0.000564	0.00165	CcSEcCtD
Ropivacaine—Pruritus—Lovastatin—atherosclerosis	0.000557	0.00163	CcSEcCtD
Ropivacaine—Asthenia—Ezetimibe—atherosclerosis	0.000554	0.00162	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Niacin—atherosclerosis	0.000552	0.00162	CcSEcCtD
Ropivacaine—Nausea—Rosuvastatin—atherosclerosis	0.000551	0.00161	CcSEcCtD
Ropivacaine—Feeling abnormal—Pravastatin—atherosclerosis	0.000548	0.0016	CcSEcCtD
Ropivacaine—Pruritus—Ezetimibe—atherosclerosis	0.000546	0.0016	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000544	0.00159	CcSEcCtD
Ropivacaine—Hypersensitivity—Simvastatin—atherosclerosis	0.000542	0.00159	CcSEcCtD
Ropivacaine—Diarrhoea—Lovastatin—atherosclerosis	0.000538	0.00158	CcSEcCtD
Ropivacaine—Urticaria—Niacin—atherosclerosis	0.000537	0.00157	CcSEcCtD
Ropivacaine—Abdominal pain—Niacin—atherosclerosis	0.000534	0.00156	CcSEcCtD
Ropivacaine—Body temperature increased—Niacin—atherosclerosis	0.000534	0.00156	CcSEcCtD
Ropivacaine—Urticaria—Pravastatin—atherosclerosis	0.000528	0.00155	CcSEcCtD
Ropivacaine—Asthenia—Simvastatin—atherosclerosis	0.000528	0.00155	CcSEcCtD
Ropivacaine—Diarrhoea—Ezetimibe—atherosclerosis	0.000528	0.00155	CcSEcCtD
Ropivacaine—Body temperature increased—Pravastatin—atherosclerosis	0.000526	0.00154	CcSEcCtD
Ropivacaine—Abdominal pain—Pravastatin—atherosclerosis	0.000526	0.00154	CcSEcCtD
Ropivacaine—Pruritus—Simvastatin—atherosclerosis	0.000521	0.00152	CcSEcCtD
Ropivacaine—Dizziness—Lovastatin—atherosclerosis	0.00052	0.00152	CcSEcCtD
Ropivacaine—Dizziness—Ezetimibe—atherosclerosis	0.00051	0.00149	CcSEcCtD
Ropivacaine—Diarrhoea—Simvastatin—atherosclerosis	0.000503	0.00147	CcSEcCtD
Ropivacaine—Vomiting—Lovastatin—atherosclerosis	0.0005	0.00146	CcSEcCtD
Ropivacaine—Hypersensitivity—Niacin—atherosclerosis	0.000498	0.00146	CcSEcCtD
Ropivacaine—Rash—Lovastatin—atherosclerosis	0.000496	0.00145	CcSEcCtD
Ropivacaine—Dermatitis—Lovastatin—atherosclerosis	0.000496	0.00145	CcSEcCtD
Ropivacaine—Headache—Lovastatin—atherosclerosis	0.000493	0.00144	CcSEcCtD
Ropivacaine—Vomiting—Ezetimibe—atherosclerosis	0.000491	0.00144	CcSEcCtD
Ropivacaine—Hypersensitivity—Pravastatin—atherosclerosis	0.00049	0.00143	CcSEcCtD
Ropivacaine—Dizziness—Simvastatin—atherosclerosis	0.000487	0.00142	CcSEcCtD
Ropivacaine—Rash—Ezetimibe—atherosclerosis	0.000486	0.00142	CcSEcCtD
Ropivacaine—Dermatitis—Ezetimibe—atherosclerosis	0.000486	0.00142	CcSEcCtD
Ropivacaine—Asthenia—Niacin—atherosclerosis	0.000485	0.00142	CcSEcCtD
Ropivacaine—Headache—Ezetimibe—atherosclerosis	0.000483	0.00141	CcSEcCtD
Ropivacaine—Pruritus—Niacin—atherosclerosis	0.000478	0.0014	CcSEcCtD
Ropivacaine—Asthenia—Pravastatin—atherosclerosis	0.000477	0.0014	CcSEcCtD
Ropivacaine—Pruritus—Pravastatin—atherosclerosis	0.000471	0.00138	CcSEcCtD
Ropivacaine—Vomiting—Simvastatin—atherosclerosis	0.000468	0.00137	CcSEcCtD
Ropivacaine—Nausea—Lovastatin—atherosclerosis	0.000467	0.00137	CcSEcCtD
Ropivacaine—Rash—Simvastatin—atherosclerosis	0.000464	0.00136	CcSEcCtD
Ropivacaine—Dermatitis—Simvastatin—atherosclerosis	0.000463	0.00136	CcSEcCtD
Ropivacaine—Diarrhoea—Niacin—atherosclerosis	0.000462	0.00135	CcSEcCtD
Ropivacaine—Headache—Simvastatin—atherosclerosis	0.000461	0.00135	CcSEcCtD
Ropivacaine—Nausea—Ezetimibe—atherosclerosis	0.000458	0.00134	CcSEcCtD
Ropivacaine—Diarrhoea—Pravastatin—atherosclerosis	0.000455	0.00133	CcSEcCtD
Ropivacaine—Dizziness—Niacin—atherosclerosis	0.000447	0.00131	CcSEcCtD
Ropivacaine—Dizziness—Pravastatin—atherosclerosis	0.00044	0.00129	CcSEcCtD
Ropivacaine—Nausea—Simvastatin—atherosclerosis	0.000437	0.00128	CcSEcCtD
Ropivacaine—Vomiting—Niacin—atherosclerosis	0.00043	0.00126	CcSEcCtD
Ropivacaine—Rash—Niacin—atherosclerosis	0.000426	0.00125	CcSEcCtD
Ropivacaine—Dermatitis—Niacin—atherosclerosis	0.000426	0.00125	CcSEcCtD
Ropivacaine—Headache—Niacin—atherosclerosis	0.000423	0.00124	CcSEcCtD
Ropivacaine—Vomiting—Pravastatin—atherosclerosis	0.000423	0.00124	CcSEcCtD
Ropivacaine—Rash—Pravastatin—atherosclerosis	0.000419	0.00123	CcSEcCtD
Ropivacaine—Dermatitis—Pravastatin—atherosclerosis	0.000419	0.00123	CcSEcCtD
Ropivacaine—Headache—Pravastatin—atherosclerosis	0.000417	0.00122	CcSEcCtD
Ropivacaine—Nausea—Niacin—atherosclerosis	0.000401	0.00117	CcSEcCtD
Ropivacaine—Nausea—Pravastatin—atherosclerosis	0.000395	0.00116	CcSEcCtD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	3.76e-05	0.000807	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MAPK3—atherosclerosis	3.74e-05	0.000803	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TNF—atherosclerosis	3.71e-05	0.000797	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	3.69e-05	0.000792	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TGFB1—atherosclerosis	3.68e-05	0.000791	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TGFB1—atherosclerosis	3.68e-05	0.000791	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	3.63e-05	0.000778	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—AKT1—atherosclerosis	3.57e-05	0.000767	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TNF—atherosclerosis	3.57e-05	0.000766	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TNF—atherosclerosis	3.57e-05	0.000766	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TNF—atherosclerosis	3.44e-05	0.000738	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TNF—atherosclerosis	3.44e-05	0.000738	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	3.35e-05	0.000719	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	3.26e-05	0.0007	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	3.18e-05	0.000682	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	3.18e-05	0.000682	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	3.18e-05	0.000682	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	3.18e-05	0.000682	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP9—atherosclerosis	3.14e-05	0.000674	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	3.14e-05	0.000673	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6—atherosclerosis	3.13e-05	0.000672	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NFKB1—atherosclerosis	3.11e-05	0.000667	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLTP—atherosclerosis	3.07e-05	0.000658	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	3.03e-05	0.00065	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCG1—atherosclerosis	3.02e-05	0.000649	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.01e-05	0.000646	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6—atherosclerosis	3e-05	0.000643	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2.97e-05	0.000637	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	2.91e-05	0.000624	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—AKT1—atherosclerosis	2.89e-05	0.00062	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—atherosclerosis	2.88e-05	0.000618	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6—atherosclerosis	2.88e-05	0.000618	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—FABP4—atherosclerosis	2.84e-05	0.00061	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LCAT—atherosclerosis	2.84e-05	0.00061	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—atherosclerosis	2.82e-05	0.000606	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	2.8e-05	0.0006	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—STAT3—atherosclerosis	2.79e-05	0.0006	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOA4—atherosclerosis	2.79e-05	0.000599	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—atherosclerosis	2.78e-05	0.000596	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—atherosclerosis	2.78e-05	0.000596	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—AKT1—atherosclerosis	2.76e-05	0.000593	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	2.76e-05	0.000593	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP7A1—atherosclerosis	2.74e-05	0.000589	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—atherosclerosis	2.73e-05	0.000587	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.7e-05	0.00058	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MAPK3—atherosclerosis	2.67e-05	0.000573	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LTA4H—atherosclerosis	2.66e-05	0.000571	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCG8—atherosclerosis	2.66e-05	0.000571	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—AKT1—atherosclerosis	2.66e-05	0.00057	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—AKT1—atherosclerosis	2.66e-05	0.00057	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLTP—atherosclerosis	2.6e-05	0.000558	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TGFB1—atherosclerosis	2.59e-05	0.000556	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT1—atherosclerosis	2.56e-05	0.00055	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT1—atherosclerosis	2.56e-05	0.00055	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP27A1—atherosclerosis	2.53e-05	0.000544	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—atherosclerosis	2.42e-05	0.000519	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.41e-05	0.000517	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALOX15—atherosclerosis	2.4e-05	0.000516	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALOX5AP—atherosclerosis	2.4e-05	0.000516	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PLA2G2A—atherosclerosis	2.4e-05	0.000516	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOA2—atherosclerosis	2.4e-05	0.000516	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.39e-05	0.000514	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.38e-05	0.00051	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCG5—atherosclerosis	2.37e-05	0.000509	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.32e-05	0.000499	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LPA—atherosclerosis	2.29e-05	0.000492	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCG8—atherosclerosis	2.25e-05	0.000484	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LTA4H—atherosclerosis	2.25e-05	0.000484	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.22e-05	0.000477	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—BGN—atherosclerosis	2.22e-05	0.000476	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOA5—atherosclerosis	2.2e-05	0.000472	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.13e-05	0.000458	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PLA2G1B—atherosclerosis	2.12e-05	0.000454	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.1e-05	0.000451	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.1e-05	0.000451	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALOX5—atherosclerosis	2.04e-05	0.000439	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLTP—atherosclerosis	2.01e-05	0.00043	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LCAT—atherosclerosis	1.98e-05	0.000424	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—FABP4—atherosclerosis	1.98e-05	0.000424	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—atherosclerosis	1.95e-05	0.000419	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOA4—atherosclerosis	1.94e-05	0.000416	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.91e-05	0.000409	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.87e-05	0.000402	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NAMPT—atherosclerosis	1.83e-05	0.000393	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LIPC—atherosclerosis	1.82e-05	0.000391	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOC3—atherosclerosis	1.81e-05	0.000388	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT1—atherosclerosis	1.8e-05	0.000386	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LDLR—atherosclerosis	1.8e-05	0.000386	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.78e-05	0.000382	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.76e-05	0.000378	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CETP—atherosclerosis	1.76e-05	0.000377	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.74e-05	0.000373	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.74e-05	0.000373	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SCARB1—atherosclerosis	1.68e-05	0.000361	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—FABP4—atherosclerosis	1.67e-05	0.000359	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LCAT—atherosclerosis	1.67e-05	0.000359	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.67e-05	0.000358	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOA2—atherosclerosis	1.67e-05	0.000358	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.67e-05	0.000358	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.67e-05	0.000358	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.65e-05	0.000354	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOA4—atherosclerosis	1.64e-05	0.000353	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.61e-05	0.000347	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LPA—atherosclerosis	1.59e-05	0.000342	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HMGCR—atherosclerosis	1.59e-05	0.000341	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—BGN—atherosclerosis	1.54e-05	0.000331	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.54e-05	0.00033	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.53e-05	0.000328	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.49e-05	0.00032	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.47e-05	0.000316	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.47e-05	0.000315	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.43e-05	0.000308	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.42e-05	0.000305	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCA1—atherosclerosis	1.42e-05	0.000304	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOA2—atherosclerosis	1.41e-05	0.000304	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.41e-05	0.000304	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.41e-05	0.000304	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.41e-05	0.000304	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.4e-05	0.0003	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.4e-05	0.0003	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.37e-05	0.000295	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LPA—atherosclerosis	1.35e-05	0.00029	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—BGN—atherosclerosis	1.31e-05	0.000281	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.3e-05	0.000279	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOA5—atherosclerosis	1.29e-05	0.000278	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.29e-05	0.000277	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.29e-05	0.000277	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.27e-05	0.000273	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.27e-05	0.000272	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.27e-05	0.000272	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.26e-05	0.00027	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.26e-05	0.00027	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.25e-05	0.000268	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.25e-05	0.000267	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.25e-05	0.000267	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.23e-05	0.000264	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CETP—atherosclerosis	1.22e-05	0.000262	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.22e-05	0.000262	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.22e-05	0.000261	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HMOX1—atherosclerosis	1.22e-05	0.000261	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.2e-05	0.000258	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.17e-05	0.000251	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOB—atherosclerosis	1.16e-05	0.00025	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.15e-05	0.000247	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTM1—atherosclerosis	1.13e-05	0.000243	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.11e-05	0.000239	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LPL—atherosclerosis	1.11e-05	0.000239	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.1e-05	0.000237	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.09e-05	0.000234	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.09e-05	0.000234	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.09e-05	0.000234	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.09e-05	0.000234	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GPX1—atherosclerosis	1.08e-05	0.000233	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.08e-05	0.000232	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.08e-05	0.000231	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.07e-05	0.00023	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LIPC—atherosclerosis	1.07e-05	0.00023	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOC3—atherosclerosis	1.07e-05	0.000229	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LDLR—atherosclerosis	1.06e-05	0.000227	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CD36—atherosclerosis	1.06e-05	0.000227	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LPA—atherosclerosis	1.04e-05	0.000224	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CETP—atherosclerosis	1.03e-05	0.000222	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—BGN—atherosclerosis	1.01e-05	0.000217	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTHFR—atherosclerosis	1e-05	0.000215	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOA5—atherosclerosis	9.99e-06	0.000214	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SCARB1—atherosclerosis	9.91e-06	0.000213	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCA1—atherosclerosis	9.84e-06	0.000211	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARA—atherosclerosis	9.82e-06	0.000211	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.65e-06	0.000207	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9.61e-06	0.000206	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AGT—atherosclerosis	9.51e-06	0.000204	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HMGCR—atherosclerosis	9.36e-06	0.000201	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOE—atherosclerosis	9.31e-06	0.0002	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.28e-06	0.000199	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CAV1—atherosclerosis	9.23e-06	0.000198	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOA1—atherosclerosis	9.21e-06	0.000198	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HMOX1—atherosclerosis	8.44e-06	0.000181	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.44e-06	0.000181	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	8.41e-06	0.00018	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCA1—atherosclerosis	8.34e-06	0.000179	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.33e-06	0.000179	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LIPC—atherosclerosis	8.28e-06	0.000178	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOC3—atherosclerosis	8.22e-06	0.000177	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LDLR—atherosclerosis	8.17e-06	0.000175	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARG—atherosclerosis	8.11e-06	0.000174	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOB—atherosclerosis	8.09e-06	0.000174	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CETP—atherosclerosis	7.98e-06	0.000171	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—INS—atherosclerosis	7.96e-06	0.000171	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTM1—atherosclerosis	7.87e-06	0.000169	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LPL—atherosclerosis	7.72e-06	0.000166	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.65e-06	0.000164	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPX1—atherosclerosis	7.54e-06	0.000162	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CD36—atherosclerosis	7.34e-06	0.000158	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALB—atherosclerosis	7.3e-06	0.000157	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.22e-06	0.000155	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HMOX1—atherosclerosis	7.15e-06	0.000154	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NOS3—atherosclerosis	6.98e-06	0.00015	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.95e-06	0.000149	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOB—atherosclerosis	6.85e-06	0.000147	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARA—atherosclerosis	6.82e-06	0.000146	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTM1—atherosclerosis	6.67e-06	0.000143	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AGT—atherosclerosis	6.61e-06	0.000142	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LPL—atherosclerosis	6.54e-06	0.00014	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOE—atherosclerosis	6.47e-06	0.000139	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.44e-06	0.000138	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CAV1—atherosclerosis	6.41e-06	0.000138	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOA1—atherosclerosis	6.4e-06	0.000137	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPX1—atherosclerosis	6.38e-06	0.000137	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS2—atherosclerosis	6.38e-06	0.000137	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CD36—atherosclerosis	6.22e-06	0.000133	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.89e-06	0.000126	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.84e-06	0.000125	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARA—atherosclerosis	5.78e-06	0.000124	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARG—atherosclerosis	5.64e-06	0.000121	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AGT—atherosclerosis	5.6e-06	0.00012	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—INS—atherosclerosis	5.53e-06	0.000119	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.52e-06	0.000119	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOE—atherosclerosis	5.48e-06	0.000118	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CAV1—atherosclerosis	5.43e-06	0.000117	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOA1—atherosclerosis	5.42e-06	0.000116	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOB—atherosclerosis	5.29e-06	0.000114	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.14e-06	0.00011	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALB—atherosclerosis	5.07e-06	0.000109	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LPL—atherosclerosis	5.05e-06	0.000108	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.95e-06	0.000106	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPX1—atherosclerosis	4.93e-06	0.000106	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NOS3—atherosclerosis	4.85e-06	0.000104	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CD36—atherosclerosis	4.8e-06	0.000103	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARG—atherosclerosis	4.78e-06	0.000103	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—INS—atherosclerosis	4.69e-06	0.000101	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.55e-06	9.76e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARA—atherosclerosis	4.46e-06	9.57e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.44e-06	9.52e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AGT—atherosclerosis	4.32e-06	9.27e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALB—atherosclerosis	4.3e-06	9.22e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOE—atherosclerosis	4.23e-06	9.08e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CAV1—atherosclerosis	4.19e-06	9e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOA1—atherosclerosis	4.18e-06	8.98e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NOS3—atherosclerosis	4.11e-06	8.82e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.82e-06	8.2e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.76e-06	8.07e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARG—atherosclerosis	3.69e-06	7.91e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—INS—atherosclerosis	3.62e-06	7.76e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALB—atherosclerosis	3.32e-06	7.12e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKT1—atherosclerosis	3.21e-06	6.88e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NOS3—atherosclerosis	3.17e-06	6.81e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.9e-06	6.22e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKT1—atherosclerosis	2.23e-06	4.79e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.89e-06	4.05e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.46e-06	3.13e-05	CbGpPWpGaD
